Supplemental Material and Methods
solution for 48 h. Cell viability was assessed by the addition of 3-(4,5-dimethylthiazo-2-yl-02,5-diphenyltetrazolium bromide (MTT, Sigma, St. Louis, MO) at a final concentration of 0.5 mg/mL, incubation for another 60 min at 37°C, and release of the blue pigment produced by viable cells using 50 µL 0.5% (w/v) sodium dodecyl sulfate, 25 mM HCl in 90 % (v/v) isopropanol. A plate reader was used to read the A570 values for each well, and percent viability was calculated relative to wells which were not treated with toxin.
For toxin neutralization assay, toxin solutions (0.25 µg/mL PA and 10 ng/mL of the FP59 variants) were pre-incubated with varying dilutions of polyclonal mouse anti-PA or mouse anti-LF antibodies for 60 min at 37°C prior to adding the toxins on CHO CL6 cells. Cells were incubated with toxin-antibody solution for 48 h and relative cell survival was determined as described above.
-lactamase activity assay
LFn--lactamase (LFnBla 1 ) fusion protein (100 µL of 0.1 µg/mL LFnBla or LFnBla rm) was tested for -lactamase enzymatic activity by incubation with the substrate Nitrocefin (100 µg/mL Nitrocefin in 100 µL PBS) in a 96-well plate. The absorbance was measured at 486 nm for 1 h every 5 min.
Cellular activity of LFnBla and LFnBla rm was tested on CHO CL6 cells. 40,000 CHO CL6 cells/well were seeded overnight and subsequently treated for 1 h at 37 °C with 250 ng/mL PA and 0.05-5 nM LFnBla or LFnBla rm. Cells were washed twice with PBS and incubated with 100 µL cell medium and 20 µl CCF2-AM loading solution (Life Technologies, Grand Island, NY) for 3 h at room temperature. -lactamase activity in cells was determined by fluorescence measurement at 447 and 520 nm on a Safire spectral fluorescence photometer using the Magellan 5 software (Tecan, Maennedorf, Switzerland).
Cytotoxicity assay for LFnCdtB and SE
LFn-cytolethal distending toxin B (LFnCdtB) and saporin-epidermal growth factor (SE 
cAMP release assay for EF
Anthrax edema factor (EF) was reductively methylated as described for FP59 and FP59AGG.
Two different EF variants (1 ng/mL) have been used for the reductive methylation, EF with an N-terminal alanine (EF-A) and with an N-terminal arginine (EF-R). EF-A was reported as one of the most stable EF-variants, while EF-R is one of the least stable EF variant in cells 3 .
Furthermore, both variants have been reductively methylated in the presence of 2 mM rat calmodulin (CaM) and 2 mM CaCl2 to protect lysines at CaM-binding sites from dimethylation.
cAMP generation by the EF variants was determined in the presence of 1 mM ATP, 80 µg/mL bovine serum albumin, and 2 mM MnCl2 for 30 min at room temperature. cAMP detection was performed with the HTRF cAMP HiRange Kit (Cisbio US, Bedford, MA) according to the manufacturer's protocol. 
